Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Trimethoprim and nitrofurantoin POM-to-P switches abandoned

By News team

Applications to reclassify trimethoprim and nitrofurantoin to over-the-counter status have been withdrawn by the drug companies behind the switch requests.

Actavis has confirmed that its application to make its trimethoprim preparation Cysticlear a pharmacy medicine for the treatment of urinary tract infections has been withdrawn. Goldshield also confirmed that it has withdrawn its request to reclassify its nitrofurantoin product Cystobid for the same indication.

The switch applications had attracted criticism from experts, including the British Society for Antimicrobial Chemotherapy, which is concerned about the development of antimicrobial resistance and the control and prevention of Clostridium difficile infection (PJ Online, 1 September 2008).

A spokeswoman for Actavis was unable to give a reason for the withdrawal but said that the company will continue to pursue its POM-to-P pipeline in other therapeutic areas.

Citation: The Pharmaceutical Journal URI: 11008849

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Shelves of medicines

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.